Ropes & Gray advised ImmunoGen on the deal.ImmunoGen, a leader in the field of antibody-drug conjugates for the treatment of cancer, announced a global, multi-year licensing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
